Graves’ orbitopathy is a potentially sight-threatening disease for which available medical therapy is not uniformly successful. Multiple case series suggest that rituximab may be effective therapy for GO patients.
To determine the efficacy of rituximab in Graves’ orbitopathy.
Twenty five patients with active moderate to severe Graves’ orbitopathy were enrolled, and 21 completed the study to the primary endpoint.
READ FULL ARTICLE From press.endocrine.org